Dynavax Technologies
DVAX
#4888
Rank
C$2.46 B
Marketcap
C$21.03
Share price
38.19%
Change (1 day)
12.42%
Change (1 year)

Dynavax Technologies (DVAX) - Cash on Hand

Cash on Hand as of September 2025 : C$0.88 Billion

According to Dynavax Technologies 's latest financial reports the company has C$0.88 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Dynavax Technologies - Cash on Hand chart (from 2003 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31C$1.02 B4.04%
2023-12-31C$0.98 B16.2%
2022-12-31C$0.84 B21.77%
2021-12-31C$0.69 B230.64%
2020-12-31C$0.21 B6.66%
2019-12-31C$0.19 B-0.49%
2018-12-31C$0.19 B-17.81%
2017-12-31C$0.24 B120.46%
2016-12-31C$0.10 B-59.79%
2015-12-31C$0.27 B91.14%
2014-12-31C$0.14 B-29.39%
2013-12-31C$0.20 B62.01%
2012-12-31C$0.12 B7.34%
2011-12-31C$0.11 B60.72%
2010-12-31C$72.12 M86.67%
2009-12-31C$38.63 M-53.6%
2008-12-31C$83.25 M-5.43%
2007-12-31C$88.03 M3.82%
2006-12-31C$84.79 M-3.03%
2005-12-31C$87.44 M10.57%
2004-12-31C$79.08 M109.53%
2003-12-31C$37.74 M-18.74%
2002-12-31C$46.45 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Agenus
AGEN
C$4.72 M-99.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$5.41 B 511.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$24.90 B 2,711.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$10.04 B 1,034.43%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$11.18 B 1,163.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
C$6.07 B 586.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
C$20.48 B 2,213.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$3.01 B 240.07%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
C$12.91 B 1,357.98%๐Ÿ‡บ๐Ÿ‡ธ USA